In ophthalmological clinical trials, sociodemographic disparities still exist.

Published Date: 01 Mar 2023

Ophthalmological Clinical Trials Still Show Sociodemographic Disparities.

Read Full News

Latest News

Eye Pain and Deteriorating Vision After Treatment for Macular Degeneration

Case highlights risk-benefit considerations with concurrent bilateral intravitreal injections

Eyeball Tattoo Goes Sideways

Irritation began after a swim in the Mediterranean

Lost to Follow-Up Predictors in Wet AMD

Travel distance, race/ethnicity, male sex boost odds, may inform adherence strategies

Should Optometry Play a Bigger Role in Wet AMD Monitoring?

Study supports it but ophthalmologist warns against expanding optometry scope of practice

Satralizumab Shows Promise for Thyroid Eye Disease

An antibody targeting the interleukin-6 receptor may help reduce bulging of the eyes and inflammation in patients with thyroid eye disease, early phase 3 data show.

Retinal Reflections: Sustained Delivery in Retinal Vascular Disease-From Evidence to Implementation

Retinal Reflections: Sustained Delivery in Retinal Vascular Disease-From Evidence to Implementation

Todays Updates

A Surgical First for Removal of an Appendiceal Neoplasm

Technique deemed safe and feasible for selected patients and better than other minimally invasive approaches

What's Behind the Mysterious Chest Pain in Bladder Cancer Patient?

Cardiomyopathy risks interrupting cancer treatment, worsening prognosis

Cancer Deaths Fall, Cases Rise; Diabetes and Cancer Risk; Vitamin C for Cancer

— News, features, and commentary about cancer-related issues

Todays Updates

A Surgical First for Removal of an Appendiceal Neoplasm

Technique deemed safe and feasible for selected patients and better than other minimally invasive approaches

What's Behind the Mysterious Chest Pain in Bladder Cancer Patient?

Cardiomyopathy risks interrupting cancer treatment, worsening prognosis

Cancer Deaths Fall, Cases Rise; Diabetes and Cancer Risk; Vitamin C for Cancer

— News, features, and commentary about cancer-related issues

Latest News

Case highlights risk-benefit considerations with concurrent bilateral intravitreal injections

Irritation began after a swim in the Mediterranean

Travel distance, race/ethnicity, male sex boost odds, may inform adherence strategies

Study supports it but ophthalmologist warns against expanding optometry scope of practice

An antibody targeting the interleukin-6 receptor may help reduce bulging of the eyes and inflammation in patients with thyroid eye disease, early phase 3 data show.

Retinal Reflections: Sustained Delivery in Retinal Vascular Disease-From Evidence to Implementation

News All Time

Branded Bevacizumab Approved for Wet AMD

Approval follows 20 years of off-label use of compounded formulations of the VEGF inhibitor

Use of PDE5 Inhibitor Tied to Increased Glaucoma Risk

Findings add to existing evidence linking the drug class to ophthalmic conditions

Medicare's Paying Less for Cataract Surgery. Ophthalmologists Are Turning to Lasers.

— Doctors typically charge $1,000 to $3,000 per eye for use of the laser

Medicare Is Paying Less for Cataract Surgery

Medicare pays doctors about $520 for a standard cataract procedure, down about 20% in the past decade.

EyePoint's Drug for Age-related Eye Disease Fails Late-stage Trial, Shares Tank

EyePoint said its experimental drug missed the main goal in a late-stage trial as a few patients lost vision ⁠from causes unrelated to the targeted disease, sending its...

Massage Matches Clinic Probing for Infant Tear Duct Blockage

Gently massaging the tear sacs of infants with blocked tear ducts may be as effective as clinic-based probing for clearing tearing and discharge, a noninferiority trial finds.

Can Dexamethasone Drops Prevent Retinal Disease in Preemies?

Dexamethasone eye drops administered in premature infants with early-stage retinal disease appear to reduce the odds of progression to treatment-requiring disease.

Urinary Drug Tadalafil Linked to Glaucoma Risk

Men taking tadalafil for lower urinary tract symptoms face a 22% higher risk of developing glaucoma than those who do not take the drug, a new study finds.

Study Links Uveitis to Higher Risk for Psychiatric Illness

Noninfectious uveitis is linked to higher rates of psychiatric comorbidities, with Black patients most affected, a new study finds.

Nonvalved Drainage Device Benefits Kids With Glaucoma

In children with difficult-to-treat glaucoma, a nonvalved implant yields sustained reductions in intraocular pressure and medication burden for up to 5 years.

What Is Causing Progressive Vision Problems in a 32-Year-Old Woman?

A glaucoma diagnosis at a young age should prompt timely genetic testing

Woman Develops Chorioretinal Anastomosis at Site of Photocoagulation Scar

A serendipitous iatrogenic effect following laser surgery in a patient with NF1

Sustained Strategies in Retina: Advancing Long-Acting Therapies for Retinal Vascular Disease

Sustained Strategies in Retina: Advancing Long-Acting Therapies for Retinal Vascular Disease

Real Retinal Decisions: A Clinical Case Challenge in Personalized Retinal Vascular Disease Treatment

Real Retinal Decisions: A Clinical Case Challenge in Personalized Retinal Vascular Disease Treatment

Focus Refined: Applying Emerging Evidence in Pharmacologic Presbyopia Management

Focus Refined: Applying Emerging Evidence in Pharmacologic Presbyopia Management

GLP-1 Drug Linked to Cases of Rare Vision-Altering Condition

Resolution occurred after stopping dulaglutide, no obvious clues to mechanism

Recommended News For You

recognizing the mechanism by which the replication of the host cell is outperformed by the skin cancer virus.

Non-Factor Therapies in Hemophilia: Cutting-Edge Approaches to Individualize Care

Nonpharmacologics May Reduce Anxiety, Depression in SUD

On all CAR-T products, the FDA is calling for a new boxed warning.

Lower screening age calls for more tailored bowel cancer surveillance

Gene therapies for BCG-unresponsive bladder cancer have high response rates.

A study has developed molecular markers that predict meningioma recurrence.

Recommended Articles For You

Intrapancreatic Fat, Pancreatitis, and Cancer: Role of Cancer-Associated Fibroblasts 

Chondroma: What it is and How it Affects Your Health  

The Millionaire's Battle: Does Mark Cuban Have Cancer? 

Digital Blood Cell Morphology Libraries for Longitudinal Hematologic Monitoring 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

According to new studies, some cancer patients can safely forego radiation therapy.

2.

Upping Immunotherapy Activity; A Win for Lung Screening; Looming Drug Price Break?

3.

The FDA approves Enhertu for HER2-positive cancers, regardless of tumor type.

4.

Can Exercise Extend Survival After Breast Cancer?

5.

e-Cigarettes and Lung Cancer: Is Harm Reduction Overstated?

1.

Digital Oncology Ecosystems Integrating Longitudinal Patient Trajectories: Transforming Cancer Care through Data-Driven Innovation

2.

Connected Transfusion Monitoring: Advancing Safety and Efficacy in Blood Transfusion Practice

3.

Robotic Intratumoral Resection for Organ Preservation: Advances, Evidence, and Clinical Implications

4.

Blood-Cell Morphology Foundation Models: Transforming Hematological Diagnostics and Clinical Practice

5.

Unlocking the Potential of SABCS 2022: Innovative Strategies for Cancer Research

1.

International Cancer Conference

2.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

3.

International Cancer Conference

4.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

1.

Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part III

2.

Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part II

3.

Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part VII

4.

Current Scenario of Cancer- Q&A Session to Close the Gap

5.

What Therapy Would Yield the Best Outcomes In Patients with R/R B-cell ALL?


Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot